The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 328 participants.
Also called NCT04129125
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 328 participants
- Sponsor
- Imperative Care, Inc.
- Registry
-
NCT04129125
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04129125. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-01 (actual); primary completion 2024-05-28 (actual). Results posted on 2025-08-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
- Condition
- Ischemic Stroke
- Condition
- Acute Stroke
- Intervention (Device)
- Zoom Reperfusion System
- Lead sponsor
- Imperative Care, Inc.
Record details
- Record id
cardio:ct-nct04129125- Content hash
2463f5d0f8c95b6cb868e07575f5b69938574f36a2ed083be5a3d8dbdf617af6